The clinical effect of a combined technical system for bicuspid aortic valves repair
- VernacularTitle:主动脉瓣二叶畸形外科修复技术体系的临床疗效分析
- Author:
Wei HAN
1
;
Yixin JIA
1
;
Xu MENG
1
;
Yuqing JIAO
1
;
Yan LI
1
;
Jie HAN
1
;
Shengyu WANG
1
;
Zonghao CHEN
1
Author Information
1. Beijing Anzhen Hospital Affiliated to Capital Medical University, Beijing, 100029, P. R. China
- Publication Type:Journal Article
- Keywords:
Bicuspid aortic valves;
aortic regurgitation;
repair;
surgery
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(07):1014-1018
- CountryChina
- Language:Chinese
-
Abstract:
Objective To summarize the clinical result of a combined technical system for bicuspid aortic valve (BAV) repair. Methods Patients who diagnosed as BAV and sever aortic regurgitation (AR) underwent a strategy of combined repair technics including annuloplasty, sinus plasty, leaflet plasty, sinus-tubular junction (STJ) plasty depending on anatomy pathological characteristics between October 2019 and January 2021 were enrolled. The clinical data of the patients were analyzed. Results A total of 17 patients were enrolled. There were 11 males and 6 females with an average age of 18-49 (32.4±13.6) years. Fifteen patients had typeⅠand 2 patients had typeⅡBAV according to Sievers classification. Annuloplasty was applicated in 13 patients, sinus plasty in 8 patients, leaflet plasty in 17 patients, and STJ plasty in 11 patients, respectively. The cardiopulmonary bypass (CPB) time was 95 (84, 135) min, aortic cross-clamping time was 68 (57, 112) min, and the ICU stay time was 17 (12, 25) h. After the operation, mild AR was presented in 14 patients, moderate AR in 1 patient and severe AR in 2 patients. The latter 3 patients underwent second operation under CPB, after then, 1 patient had mild AR and 2 patients had moderate AR. The follow-up time was 13.1±4.6 months. At the latest follow-up, 12 patients had mild AR and 5 patients had moderate AR, and no patient had reoperation. Conclusion A combined technical system for BAV repair can be used effectively and safely with an acceptable short and middle-term result.
